Browsing: Inhalers

– 202402sandersbernie 020824ar01 w

AstraZeneca will limit the price of inhalers to $35 a month after facing close examination, following a similar move by a competitor

Business 3 Mins Read

Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday.  The cap is effective June 1 and will apply to the company’s entire range of inhaler products used to treat asthma and chronic obstructive pulmonary disease, including inhalers Symbicort, Breztri Aerosphere and Airsupra. The cap will be applicable for…